NCT04802616View on ClinicalTrials.gov

The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

October 29, 2021

Conditions
Allergic Rhinitis Due to Grass Pollen
Interventions
DRUG

Ismigen

Sublingual tablets containing 7 mg of bacterial lysate from the following bacteria: Staphylococcus aureus, Haemophilus influenzae serotype B, Klebsiella pneumoniae, Klebsiella ozaenae, Neiserria catarrhalis, Streptococcus viridans, Streptococcus pyogenes, Streptococcus pneumoniae (6 strains: TY1/EQ11, TY2/EQ22, TY3/EQ14, TY5/EQ15, TY8/EQ23, TY47/EQ24).

DRUG

Placebo

Matched tablets without any active substance.

Trial Locations (1)

20-093

Department of Pulmonary Diseases and Children Rheumatology, Medical University of Lublin, Lublin

All Listed Sponsors
lead

Medical University of Lublin

OTHER

NCT04802616 - The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells | Biotech Hunter | Biotech Hunter